(lp0
S'Galectin Therapeutics Inc. Announces Pricing of Public Offering of 1159445 ... Business Wire  - Mar 23, 2012 NEWTON, Mass.----Galectin Therapeutics Inc.  today announced the pricing of an underwritten public offering of 1,159,445 units at a price to the public of $9.00 per unit, with each unit consisting of two common voting&nbsp;...'
p1
aS'Galectin Therapeutics Issues Statement Regarding GALTW and GALTU Nasdaq - Mar 23, 2017 NORCROSS, Ga., March 23, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, announced today that trading will be halted in GALTW and GALTU at close of business on ...Trading in certain Galectin warrants ends today; trading in stock unaffected - Seeking Alpha'
p2
aS'Galectin Therapeutics  Says Combination with Galectin-3 Inhibitor GR-MD ... StreetInsider.com - Feb 7, 2017 Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, and the Providence Cancer Center today announced the presentation of preclinical and early clinical data from two investigator-initiated ...analysts Recommendations: Galectin Therapeutics, Inc.  - News Oracle'
p3
aS'Galectin Therapeutics  Receiving Somewhat Positive Press Coverage ... Sports Perspectives - Apr 10, 2017 Galectin Therapeutics logo Press coverage about Galectin Therapeutics  has trended somewhat positive on Monday, Alpha One reports.'
p4
aS'Galectin Therapeutics  Completes GR-MD-02 Phase 2 Patient Enrollment for ... StreetInsider.com - Aug 2, 2016 Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announces the completion of patient recruitment in its Phase 2 clinical trial with GR-MD-02 in patients with ...'
p5
aS"Galectin Therapeutics  Gains Again on Takeover, NASH Trial Speculation StreetInsider.com - Sep 21, 2016 Galectin Therapeutics  is surging higher again as speculators reprice NASH stocks following Allergen's  takeover of Tobira  yesterday."
p6
aS'What do Analysts suggest for: Galectin Therapeutics, Inc.  News Oracle - Sep 23, 2016 Galectin Therapeutics, Inc.  reported its last earnings on Aug 09 BMO .'
p7
aS'Zacks Rank on Galectin Therapeutics Inc.  based on Estimated Earnings Highland Mirror - Mar 17, 2017 In a strong setback, the shares of Galectin Therapeutics Inc.  have been rated as sell by 3 analysts at brokerage firms.Galectin Therapeutics  report results for severe and refractory ... - Benchmark Monitor'
p8
aS"Notable Wall Street Stock: Galectin Therapeutics, Inc.'s  stock price ... WsNews 4investors - Mar 17, 2017 Galectin Therapeutics, Inc.  stock price distance from twenty day simple moving average surged at 20.89% while its distance from fifty day simple moving average raised 56.57% along with 57.04% above distance from two hundred simple moving&nbsp;..."
p9
aS"Investors Watch-list: Galectin Therapeutics, Inc.'s  stock price settles ... WsNews 4investors - Mar 14, 2017 Galectin Therapeutics, Inc.  stock price distance from twenty day simple moving average surged at 6.31% while its distance from fifty day simple moving average raised 38.23% along with 34.05% above distance from two hundred simple moving&nbsp;..."
p10
a.